Skip to main content
69°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Akebia Therapeutics
(NQ:
AKBA
)
1.550
+0.030 (+1.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Akebia Therapeutics
< Previous
1
2
3
4
5
Next >
AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 29, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
March 28, 2024
Via
Benzinga
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
March 28, 2024
The FDA-approved Vafseo tablets by Akebia Therapeutics for managing anemia in adult dialysis patients with chronic kidney disease. Learn about its once-daily oral HIF-PH inhibitor and global approval...
Via
Benzinga
Exposures
Product Safety
Recap: Akebia Therapeutics Q4 Earnings
March 14, 2024
Via
Benzinga
Earnings Preview For Akebia Therapeutics
March 13, 2024
Via
Benzinga
Earnings Outlook For Akebia Therapeutics
November 07, 2023
Via
Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
March 28, 2024
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 28, 2024
Via
Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
March 27, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Outlook For Akebia Therapeutics
August 24, 2023
Via
Benzinga
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 15, 2024
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023
March 14, 2024
AKBA stock results show that Akebia Therapeutics beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 14, 2024
Via
Benzinga
Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars
August 28, 2023
HC Wainwright has upgraded Akebia Therapeutics Inc (NASDAQ: AKBA) from Neutral to Buy rat
Via
Benzinga
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
Earnings Scheduled For August 25, 2023
August 25, 2023
Companies Reporting Before The Bell • Hibbett (NASDAQ:HIBB) is likely to report quarterly earnings at $0.73 per share on revenue of $376.11 million.
Via
Benzinga
Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday
August 25, 2023
With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fear & Greed Index Moves To 'Fear' Zone Ahead Of Powell's Speech
August 25, 2023
The CNN Money Fear and Greed index moved to the "Fear" zone on Thursday. U.S. stocks closed sharply lower on Thursday ahead of a key speech from Federal Reserve chair Jerome Powell at the Jackson Hole...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 07, 2023
Via
Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 25, 2023
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
Via
Benzinga
Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom
July 06, 2023
Are you looking for High Return Penny Stocks for high growth? Here are three penny stocks with rapid development and great market potential.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.